Aardvark Therapeutics Inc (AARD)
Aardvark Therapeutics stock today
Aardvark Therapeutics closed at $1.36 on October 30, 2026, down 5.56% on the day. Over the past year it returned -87.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $30.0 million.
| Period | AARD | S&P 500 (SPY) |
|---|---|---|
| 1 month | -74.2% | -0.9% |
| 3 months | -78.8% | +2.1% |
| Year to date | -89.6% | +11.7% |
| 1 year | -87.0% | +12.4% |
Key statistics
- Market value
- $30.0M
- 52-week range
- $1.08 to $15.82
- Next report
- Nov 12, 2026 (estimated)
About Aardvark Therapeutics
Aardvark Therapeutics develops pharmaceutical treatments for respiratory and inflammatory diseases.
Sector: Health Care
More on Aardvark Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $130.02 today
No forecast, no recommendation. This page describes Aardvark Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.